Altered expression levels of miR-212, miR-133b and miR-27a in tongue squamous cell carcinoma (TSCC) with clinicopathological considerations

被引:2
|
作者
Azar, Mohammad Reza Mohammad Hoseini [1 ,2 ]
Shanehbandi, Dariush [3 ]
Mansouri, Mahmoud [4 ]
Sarand, Sahar Pashaei [5 ]
Asadi, Milad [2 ]
Akbari, Morteza [3 ,6 ]
Sadeghzadeh, Mahsa [2 ]
Abolghasemi, Mahsa [2 ]
Poursaei, Elham [2 ]
Gasembaglou, Shahram [2 ,7 ]
机构
[1] Urmia Univ Med Sci, Dept Gastroenterol, Imam Khomeini Med Sci, Orumiyeh, Iran
[2] Tabriz Univ Med Sci, TB & Lung Dis Res Ctr, Tabriz, Iran
[3] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[4] Univ Tehran, Sci Appl Chem, Tehran, Iran
[5] Amirkabir Univ Technol Polytech Tehran, Sci Appl Chem, Tehran, Iran
[6] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran
[7] Tabriz Univ Med Sci, Sch Med, Dept Otorhinolaryngol, Tabriz, Iran
来源
GENE REPORTS | 2020年 / 19卷
关键词
miRNA; Tongue squamous cell carcinoma; Diagnostic markers; miR-212; miR-133; miR-27a; INDIRECT MODULATORS; TUMOR-SUPPRESSOR; DOWN-REGULATION; NONCODING RNAS; CANCER; RISK; INHIBITION; BIOMARKERS; MICRORNAS; CISPLATIN;
D O I
10.1016/j.genrep.2020.100622
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: microRNAs have been reported as an important player in the carcinogenesis of different tumors. Studies are implicated their involvement in tongue squamous cell carcinoma (TSCC) creation and carcinogenesis. The aim of this study was to evaluate the expression level of five miRNAs including miR-125b, miR-124a, miR-27a, miR-212, and miR-133b in TSCC specimens. Methods: Two-step reverse transcriptase quantitative using the SYBR GREEN method assay was carried out to determine the expression level of selected miRNAs in 30 pairs of TSCC tumors and adjacent non-cancerous samples. The association between clinicopathological parameters and the expression levels of microRNAs were also studied. Results: The expression level of miR-212 and miR-133 was significantly lower in tumor tissues compared to margin mucosa (p <.05). In addition, miR-27a was elevated (p < .03) while miR-124a and miR-125b had no significant changes in both groups. Conclusion: Taken together, our results indicated that miR-212, miR-133, and miR-27a are dysregulated in tumor tissues and involved in the pathogenesis of TSCC. So, they may serve as a diagnostic and therapeutic candidate in the future.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Expression levels and clinical significance of miR-203 and miR-133b in laryngeal carcinoma
    Zhao, Na
    Liu, Hongjun
    Zhang, Aifen
    Wang, Min
    ONCOLOGY LETTERS, 2020, 20 (05)
  • [2] miR-133b Promotes Esophageal Squamous Cell Carcinoma Metastasis
    Huang, Cong-Gai
    Liu, Qing
    Zheng, Shu-Tao
    Liu, Tao
    Tan, Yi-Yi
    Peng, Tian-Yuan
    Chen, Jiao
    Lu, Xiao-Mei
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2023, 17
  • [3] Increased Expression of MiR-27a and MiR-24-2 in Esophageal Squamous Cell Carcinoma
    Maghsudlu, Mohaddese
    Farashahi Yazd, Ehsan
    Amiriani, Taghi
    JOURNAL OF GASTROINTESTINAL CANCER, 2020, 51 (01) : 227 - 233
  • [4] Increased Expression of MiR-27a and MiR-24-2 in Esophageal Squamous Cell Carcinoma
    Mohaddese Maghsudlu
    Ehsan Farashahi Yazd
    Taghi Amiriani
    Journal of Gastrointestinal Cancer, 2020, 51 : 227 - 233
  • [5] miR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma
    Kano, Masayuki
    Seki, Naohiko
    Kikkawa, Naoko
    Fujimura, Lisa
    Hoshino, Isamu
    Akutsu, Yasunori
    Chiyomaru, Takeshi
    Enokida, Hideki
    Nakagawa, Masayuki
    Matsubara, Hisahiro
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (12) : 2804 - 2814
  • [6] Expression and clinical value of miR-27a in serum of patients with skin squamous cell carcinoma
    Wang, Hui
    Wang, Songfen
    Chen, Fang
    Zhang, Chong
    Zhang, Xuguang
    Sun, Yi
    JOURNAL OF BUON, 2020, 25 (05): : 2515 - 2522
  • [7] Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics
    Manikandan, Mayakannan
    Rao, Arunagiri K. Deva Magendhra
    Rajkumar, Kottayasamy Seenivasagam
    Rajaraman, Ramamurthy
    Munirajan, Arasambattu K.
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2015, 44 (10) : 792 - 800
  • [8] miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR
    Zeng, Wei
    Zhu, Jin-Feng
    Liu, Jun-Yuan
    Li, Ying-Long
    Dong, Xiang
    Huang, He
    Shan, Li
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 111 : 476 - 484
  • [9] TUG1/miR-133b/CXCR4 axis regulates cisplatin resistance in human tongue squamous cell carcinoma
    Ke Zhang
    Hong Zhou
    Bo Yan
    Xuanping Cao
    Cancer Cell International, 20
  • [10] TUG1/miR-133b/CXCR4 axis regulates cisplatin resistance in human tongue squamous cell carcinoma
    Zhang, Ke
    Zhou, Hong
    Yan, Bo
    Cao, Xuanping
    CANCER CELL INTERNATIONAL, 2020, 20 (01)